Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 3
2005 2
2006 5
2007 3
2008 4
2009 6
2010 8
2011 4
2012 3
2013 6
2014 9
2015 2
2016 7
2017 6
2018 8
2019 6
2020 16
2021 21
2022 17
2023 16
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.
Gay CM, Stewart CA, Park EM, Diao L, Groves SM, Heeke S, Nabet BY, Fujimoto J, Solis LM, Lu W, Xi Y, Cardnell RJ, Wang Q, Fabbri G, Cargill KR, Vokes NI, Ramkumar K, Zhang B, Della Corte CM, Robson P, Swisher SG, Roth JA, Glisson BS, Shames DS, Wistuba II, Wang J, Quaranta V, Minna J, Heymach JV, Byers LA. Gay CM, et al. Among authors: ramkumar k. Cancer Cell. 2021 Mar 8;39(3):346-360.e7. doi: 10.1016/j.ccell.2020.12.014. Epub 2021 Jan 21. Cancer Cell. 2021. PMID: 33482121 Free PMC article.
Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer.
Ramkumar K, Tanimoto A, Della Corte CM, Stewart CA, Wang Q, Shen L, Cardnell RJ, Wang J, Polanska UM, Andersen C, Saeh J, Pease JE, Travers J, Fabbri G, Gay CM, Urosevic J, Byers LA. Ramkumar K, et al. Clin Cancer Res. 2023 Aug 15;29(16):3237-3249. doi: 10.1158/1078-0432.CCR-23-0375. Clin Cancer Res. 2023. PMID: 37289191 Free PMC article.
Editorial: Clinical and genetic determinants of diabetes and complications.
Li S, Delvecchio M, Ramkumar KM, Mao X, Sun X, Guo S. Li S, et al. Among authors: ramkumar km. Front Endocrinol (Lausanne). 2023 Jul 4;14:1245837. doi: 10.3389/fendo.2023.1245837. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37469979 Free PMC article. No abstract available.
Pharmacological activation of Nrf2 promotes wound healing.
Victor P, Sarada D, Ramkumar KM. Victor P, et al. Among authors: ramkumar km. Eur J Pharmacol. 2020 Nov 5;886:173395. doi: 10.1016/j.ejphar.2020.173395. Epub 2020 Jul 22. Eur J Pharmacol. 2020. PMID: 32710954 Review.
Targeting SUMOylation cascade for diabetes management.
Sireesh D, Bhakkiyalakshmi E, Ramkumar KM, Rathinakumar S, Jennifer PS, Rajaguru P, Paulmurugan R. Sireesh D, et al. Among authors: ramkumar km. Curr Drug Targets. 2014;15(12):1094-106. doi: 10.2174/1389450115666140915124747. Curr Drug Targets. 2014. PMID: 25230117 Review.
The pivotal role of Nrf2 activators in adipocyte biology.
Annie-Mathew AS, Prem-Santhosh S, Jayasuriya R, Ganesh G, Ramkumar KM, Sarada DVL. Annie-Mathew AS, et al. Among authors: ramkumar km. Pharmacol Res. 2021 Nov;173:105853. doi: 10.1016/j.phrs.2021.105853. Epub 2021 Aug 27. Pharmacol Res. 2021. PMID: 34455076 Review.
135 results